Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

An open trial of a visnadine emulgel topical application in post-menopausal superficial dyspareunia: daily vs. on-demand use.

Caputo A, Sparavigna A, Natoli A, Mandelli C.

Minerva Ginecol. 2019 Sep 20. doi: 10.23736/S0026-4784.19.04402-2. [Epub ahead of print] No abstract available.

PMID:
31560182
2.

A randomized single-blind placebo-controlled study of a Visnadine Emulgel formulation on healthy postmenopausal women.

Sparavigna A, Caputo A, Natoli A, Mandelli C.

Minerva Ginecol. 2019 Oct;71(5):353-358. doi: 10.23736/S0026-4784.19.04398-3.

PMID:
31698889
3.

Randomized crossover study investigating daily versus on-demand vulvar Visnadine spray in women affected by female sexual arousal disorder.

Caruso S, Mauro D, Cariola M, Fava V, Rapisarda AMC, Cianci A.

Gynecol Endocrinol. 2018 Feb;34(2):110-114. doi: 10.1080/09513590.2017.1354366. Epub 2017 Jul 27.

PMID:
28749253
4.

Efficacy and tolerability of a spray formulation containing Visnadine in women self-reporting sexual symptoms: a randomized double-blind placebo-controlled pilot study.

Bernorio R, Piloni S, Mori G, Prunas A, Bosoni D, Nappi RE.

J Endocrinol Invest. 2018 Jun;41(6):729-737. doi: 10.1007/s40618-017-0801-0. Epub 2017 Dec 11.

PMID:
29230716
5.

An overview of the phytoestrogen effect on vaginal health and dyspareunia in peri- and post-menopausal women.

Dizavandi FR, Ghazanfarpour M, Roozbeh N, Kargarfard L, Khadivzadeh T, Dashti S.

Post Reprod Health. 2019 Mar;25(1):11-20. doi: 10.1177/2053369118823365. Epub 2019 Feb 20. Review.

PMID:
30786797
6.

Treatment of Secondary Vestibulodynia with Conjugated Estrogen Cream: A Pilot, Double-Blind, Randomized Placebo-Controlled Trial.

Langlais EL, Lefebvre J, Maheux-Lacroix S, Bujold E, Fortier M, Bouchard C.

J Obstet Gynaecol Can. 2017 Jun;39(6):453-458. doi: 10.1016/j.jogc.2016.10.011. Epub 2017 Mar 22.

PMID:
28342741
7.

Recent expansions in an emergent novel drug delivery technology: Emulgel.

Ajazuddin, Alexander A, Khichariya A, Gupta S, Patel RJ, Giri TK, Tripathi DK.

J Control Release. 2013 Oct 28;171(2):122-32. doi: 10.1016/j.jconrel.2013.06.030. Epub 2013 Jul 2. Review.

PMID:
23831051
8.

Design and Development of Unani Emulgel for Vitiligo.

Shadab M, Shamsi S.

J Ayurveda Integr Med. 2018 Nov 17. pii: S0975-9476(17)30354-6. doi: 10.1016/j.jaim.2018.01.006. [Epub ahead of print]

9.

Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring.

Rahmani-Neishaboor E, Jallili R, Hartwell R, Leung V, Carr N, Ghahary A.

Wound Repair Regen. 2013 Jan-Feb;21(1):55-65. doi: 10.1111/j.1524-475X.2012.00857.x. Epub 2012 Nov 5.

PMID:
23126516
10.

A new topical formulation enhances relative diclofenac bioavailability in healthy male subjects.

Brunner M, Davies D, Martin W, Leuratti C, Lackner E, Müller M.

Br J Clin Pharmacol. 2011 Jun;71(6):852-9. doi: 10.1111/j.1365-2125.2011.03914.x.

11.

Evaluation of Skin Penetration of Diclofenac from a Novel Topical Non Aqueous Solution: A Comparative Bioavailability Study.

Nivsarkar M, Maroo SH, Patel KR, Patel DD.

J Clin Diagn Res. 2015 Dec;9(12):FC11-3. doi: 10.7860/JCDR/2015/15690.6956. Epub 2015 Dec 1.

12.

An approach to enhanced stability: Formulation and characterization of Solanum lycopersicum derived lycopene based topical emulgel.

Sohail M, Naveed A, Abdul R, Gulfishan, Muhammad Shoaib Khan H, Khan H.

Saudi Pharm J. 2018 Dec;26(8):1170-1177. doi: 10.1016/j.jsps.2018.07.005. Epub 2018 Jul 20.

13.

Tamanu oil potentiated novel sericin emulgel of levocetirizine: repurposing for topical delivery against DNCB-induced atopic dermatitis, QbD based development and in vivo evaluation.

Pal RR, Parashar P, Singh I, Saraf SA.

J Microencapsul. 2019 Aug;36(5):432-446. doi: 10.1080/02652048.2019.1637474. Epub 2019 Jul 9.

PMID:
31238752
14.

[Evaluation of an estrogen vaginal cream for the treatment of dyspareunia: a double-blind randomized trial].

Bazin S, Lefebvre J, Fortier M, Brisson J, Brouillette F, Bujold E, Bouchard C.

J Obstet Gynaecol Can. 2011 Aug;33(8):838-843. doi: 10.1016/S1701-2163(16)34987-8. French.

PMID:
21846439
15.

Formulation and evaluation of mefenamic acid emulgel for topical delivery.

Khullar R, Kumar D, Seth N, Saini S.

Saudi Pharm J. 2012 Jan;20(1):63-7. doi: 10.1016/j.jsps.2011.08.001. Epub 2011 Aug 22.

16.

Deep Dyspareunia and Sexual Quality of Life in Women With Endometriosis.

Shum LK, Bedaiwy MA, Allaire C, Williams C, Noga H, Albert A, Lisonkova S, Yong PJ.

Sex Med. 2018 Sep;6(3):224-233. doi: 10.1016/j.esxm.2018.04.006. Epub 2018 May 22.

17.

Intravaginally applied oxytocin improves post-menopausal vaginal atrophy.

Al-Saqi SH, Uvnäs-Moberg K, Jonasson AF.

Post Reprod Health. 2015 Sep;21(3):88-97. doi: 10.1177/2053369115577328. Epub 2015 May 19.

18.

A Practical Solution for Dyspareunia in Breast Cancer Survivors: A Randomized Controlled Trial.

Goetsch MF, Lim JY, Caughey AB.

J Clin Oncol. 2015 Oct 20;33(30):3394-400. doi: 10.1200/JCO.2014.60.7366. Epub 2015 Jul 27.

19.

Concurrent deep-superficial dyspareunia: prevalence, associations, and outcomes in a multidisciplinary vulvodynia program.

Yong PJ, Sadownik L, Brotto LA.

J Sex Med. 2015 Jan;12(1):219-27. doi: 10.1111/jsm.12729. Epub 2014 Oct 27.

PMID:
25345552
20.

Prospective multicenter observational trial on the safety and efficacy of LEVORAG® Emulgel in the treatment of acute and chronic anal fissure.

Digennaro R, Pecorella G, La Manna S, Alderisio A, Alderisio A Jr, De Pascalis B, Pennisi D, Santangelo G, Pezzolla F, Racalbuto A, Serra G, Pulvirenti D'Urso A, Altomare DF.

Tech Coloproctol. 2015 May;19(5):287-92. doi: 10.1007/s10151-015-1289-2. Epub 2015 Mar 15.

Supplemental Content

Support Center